Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$15.32 USD
+0.33 (2.20%)
Updated May 20, 2024 04:00 PM ET
After-Market: $15.33 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.65 | 0.00% |
Earnings Summary
For their last quarter, Entrada Therapeutics (TRDA) reported earnings of $0.68 per share, beating the Zacks Consensus Estimate of $-0.38 per share. This reflects a positive earnings surprise of 278.95%. Look out for TRDA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.65 per share, reflecting a year-over-year increase of 183.33%.
Earnings History
Price & Consensus
Zacks News for TRDA
Exelixis (EXEL) Posts Preliminary 2023 Results, to Cut 13% Jobs
TRDA: What are Zacks experts saying now?
Zacks Private Portfolio Services